Page last updated: 2024-08-24

triazoles and Catarrh

triazoles has been researched along with Catarrh in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergman, A; Davies, MJ; De Smet, M; Gottesdiener, KM; Herman, GA; Hilliard, D; Musson, D; Ramael, S; Snyder, K; Stevens, C; Tanaka, W; Tanen, M; Van Dyck, K; Wagner, JA; Wang, AQ; Winchell, G; Yi, B; Zeng, W1

Trials

1 trial(s) available for triazoles and Catarrh

ArticleYear
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses.
    Clinical pharmacology and therapeutics, 2005, Volume: 78, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Area Under Curve; Blood Glucose; C-Peptide; Common Cold; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Eye Diseases; Fasting; Glucagon-Like Peptide 1; Half-Life; Headache; Humans; Insulin; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Triazoles

2005